Items tagged 'gene therapy'

Professor Cedric Hermans spoke with HFA about new and emerging haemophilia therapies, women and girls, and the importance of diagnosis.
HFA has published haemophilia treatment fact sheets on clotting factor replacement therapy, bispecific antibody therapy, rebalancing therapies and gene therapy.
An Australian research study reports on the views of people with blood disorders, their carers, and the general public on gene therapy.
Clotting factor therapy, bispecific antibody therapy, rebalancing therapies and gene therapy factsheets are now available
Exciting advancements in gene therapy and other emerging treatments for haemophilia were presented at the Blood 2024 conference.

(HaemPref Survey) How do individuals make decisions about treatment? What factors encourage or discourage patients from treatments? What are individuals’…

As we wrap up 2024, HFA reflects on our achievements in new therapies, hep C advocacy and support during the year.
HFA's haemophilia gene therapy snapshot survey asked people and parents of children with haemophilia what outcomes they would like from treatment now and in the future.
Heading to the end of the year, we review our progress. Gene and emerging therapies are on the agenda, and Bleeding Disorders Awareness Month is coming up.
Haemophilia Foundation Australia President Gavin Finkelstein spoke with HFA about his experiences at the WFH 2024 World Congress.

Join the HFA community

Sign up for the latest news, events and our free National Haemophilia magazine

Skip to content